Coronavirus Market Reports News

Respiratory Distress Syndrome Market 2020: Global Industry Analysis, Size, Share, Growth, Trends and Forecast To 2026

Healthcare - Credible Markets

The recent report on “Global Respiratory Distress Syndrome Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026” offered by Credible Markets, comprises of a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Respiratory Distress Syndrome Market”.

Impact of Covid-19 in Respiratory Distress Syndrome Market: The utility-owned segment is mainly being driven by increasing financial incentives and regulatory supports from the governments globally. The current utility-owned Respiratory Distress Syndrome are affected primarily by the COVID-19 pandemic. Most of the projects in China, the US, Germany, and South Korea are delayed, and the companies are facing short-term operational issues due to supply chain constraints and lack of site access due to the COVID-19 outbreak. Asia-Pacific is anticipated to get highly affected by the spread of the COVID-19 due to the effect of the pandemic in China, Japan, and India. China is the epic center of this lethal disease. China is a major country in terms of the chemical industry.

For Better Understanding, Download FREE Sample Copy of Respiratory Distress Syndrome Report @

The following players are covered in this report:

Chiesi Farmaceutici

CR-Double Crane

ONY Biotech


Yuhan Corporation

JW Pharmaceuticals


Respiratory Distress Syndrome Breakdown Data by Type

Poractant Alfa




Poractant Alpha’s largest market share is broken down to 67%.

Respiratory Distress Syndrome Breakdown Data by Application

Very Preterm Infants

Moderate to Late Preterm Infants


Very Preterm shapes the largest segment of the application market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions 

United States, Canada, Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia, Brazil, Mexico, Argentina, Columbia, Chile, Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of the World

Enquiry before Buying this Report @

Some Points from Table of Content

Global Respiratory Distress Syndrome Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 

Chapter 1 Report Overview

Chapter 2 Global Growth Trends by Regions

Chapter 3 Competition Landscape by Key Players

Chapter 4 Breakdown Data by Type (2015-2026)

Chapter 5 Respiratory Distress Syndrome Breakdown Data by Application (2015-2026)

Chapter 6 North America

Chapter 7 Europe

Chapter 8 China

Chapter 9 Japan

Chapter 10 Southeast Asia

Chapter 11 India

Chapter 12 Central & South America

Chapter 13 Key Players Profiles

Chapter 14 Analyst’s Viewpoints/Conclusions

Chapter 15 Appendix

Direct Purchase this Report @

The research provides answers to the following key questions:

• What is the expected growth rate of the Respiratory Distress Syndrome market? What will be the market size for the forecast period, 2020 – 2026?

• What are the major driving forces responsible for transforming the trajectory of the industry?

• Who are major vendors dominating the Respiratory Distress Syndrome industry across different regions? What are their winning strategies to stay ahead in the competition?

• What are the market trends business owners can rely upon in the coming years?

• What are the threats and challenges expected to restrict the progress of the industry across different countries?

• What are the key opportunities that business owners can bank on for the forecast period, 2020 – 2026?

About Credible Markets

Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.

Ask for customization @ 

Contact Us

Credible Markets Analytics

99 Wall Street 2124 New York, NY 10005

US Contact No: +1(929)-450-2887

Email: [email protected]


Browse complete Respiratory Distress Syndrome report description And Full TOC @

Coronavirus Energy Market Reports News

Global Respiratory Distress Syndrome Market to Undergo Rapid Advancements During the COVID 19 Period

Respiratory distress syndrome is a lung disorder of neonates caused by a deficiency of surfactants. It affects premature infants with symptoms of collapsed lungs and breathing difficulty. Other symptoms include nasal flaring, use of accessory muscles and grunting respirations. Respiratory distress syndrome is a rare disorder and it affects only a few percent’s of the population. The risk of respiratory distress syndrome increases with prematurity of the infant and it is genetic in origin. Treatment of respiratory distress syndrome mainly includes positive end-expiratory pressure by the physical or mechanical assistance of breathing. Other treatments are supportive and symptomatic. FDA approved Exosurf Neonatal, Survanta, Surfactant TA, Human Surf and Dey Lab’s lung surfactants respectively. Exosurf Neonatal is the first FDA approved synthetic surfactant for the treatment of infant respiratory distress syndrome. It was manufactured by Burroughs Wellcome. Abbott is the second company to get FDA approval for Survanta, which is derived from bovine tissues. Other surfactants include Curosurf Intratracheal Suspension was approved by regulatory authorities for the treatment of respiratory distress syndrome.

Get Free Sample Copy With Impact Analysis Of COVID-19 Of Market Report @

Respiratory Distress Syndrome Market: Drivers and Restraints

According to the National Organization of Rare Diseases, respiratory distress syndrome affects more than 20% of the prematurely born infants with a mortality rate of 10%. It affects both male and female population in an equal proportion. Raising prevalence of respiratory distress syndrome along with high mortality rate boosted the growth the market. Further, rapid improvements in the field of healthcare give opportunities for raising awareness about respiratory distress syndrome. Along with these, regulatory authorities provide the drug with orphan drug status. Orphan drugs have high price elasticity and it offers manufacturers with high-profit margins than other drugs. With these, Orphan drugs also get financial assistance like tax waivers from regulatory authorities. Apart from these, non-profit organizations are promoting research & development around respiratory distress syndrome in joint scientific research between the public sector and the private sector. In association with the non-profit organization, state governments provide special incentives to the manufacturer to develop respiratory distress syndrome drugs. Public-private partnerships are encouraging pharmaceutical companies to develop new orphan drugs for Respiratory Distress Syndrome. All of these factors act as potential drivers for the growth of the respiratory distress syndrome market.

Due to lack of awareness regarding the diseases, the growth of respiratory distress syndrome market was slightly affected.

Respiratory Distress Syndrome Market: Segmentation

Segmentation based on End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores

Respiratory Distress Syndrome Market: Market Overview

Global Respiratory Distress Syndrome market has witnessed a robust growth due to increasing demand for effective treatment methods. Manufacturers are majorly concentrated on the development of novel medicines to cure the respiratory distress syndrome. Presently, non-profit organizations along with legislative bodies are taking part in raising awareness in the general population. Respiratory distress syndrome has the presence of limited manufacturers and it offers huge opportunities to innovators due to highly unmet needs. The future of respiratory distress syndrome market anticipated with double growth rate during forecasting period.

You Can Buy This PMR Healthcare Report From Here @

Respiratory Distress Syndrome Market: Region-wise Overview

Global Respiratory Distress Syndrome market is segmented into the following regions – North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and the Middle East & Africa. North America is dominant in the global respiratory distress syndrome market mainly due to the increased mortality rate of respiratory distress syndrome. In North America, particularly the USA is dominating due to high awareness of respiratory distress syndrome. Europe is a second leading player in global respiratory distress syndrome due to well-established healthcare systems. Along with this, both North America and Europe region legislations offer reimbursement for the treatment of respiratory distress syndrome. The Asia Pacific Is anticipated to the third most leading player in global respiratory distress syndrome due to the high prevalence of respiratory distress syndrome and prematurity birth of infants. However, Latin America and Middle East & Africa regions account for a small share in the global market due to lack of awareness regarding respiratory distress syndrome and it is expected to increase during the forecast period.

Respiratory Distress Syndrome Market: Key Participants

The key participants in Respiratory Distress Syndrome Market are ONY Biotech Inc., AbbVie Inc. Dey Laboratories Inc, Chiesi Farmaceutici, S.p.A., and others. The companies are mainly focusing on collaboration and partnership to keep up the pace of the competition and to develop new products.